Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vitrolife AB ( (SE:VITR) ) has issued an update.
Vitrolife AB has called its 2026 Annual General Meeting for 5 May in Gothenburg, Sweden, allowing shareholders to participate either in person or through advance postal voting in line with its Articles of Association. Shareholders must be registered by 24 April and give notice or submit postal votes by 28 April, with detailed procedures laid out for nominee-registered investors, proxies and legal entities.
The agenda includes standard governance items such as approval of financial statements, dividend decisions, discharge of the board and CEO from liability, and the remuneration report. Shareholders will also vote on board elections, reappointing several current directors and Deloitte as auditor while adding two new board members, and consider a long-term share incentive plan, new share issue and share buyback authorisations, and amendments to the Articles of Association, all of which could influence Vitrolife’s capital structure, governance framework and long-term incentive alignment.
The most recent analyst rating on (SE:VITR) stock is a Hold with a SEK89.00 price target. To see the full list of analyst forecasts on Vitrolife AB stock, see the SE:VITR Stock Forecast page.
More about Vitrolife AB
Vitrolife AB is a Swedish medical technology company focused on products and solutions for assisted reproduction and fertility treatment. The company serves clinics and healthcare providers globally with technologies that support in vitro fertilization and related reproductive procedures.
Average Trading Volume: 302,062
Technical Sentiment Signal: Sell
Current Market Cap: SEK12.77B
For an in-depth examination of VITR stock, go to TipRanks’ Overview page.